Shares of Keryx Biopharmaceuticals, Inc. (KERX) Hit 52-Week Low on Second Quarter Earnings Results
Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX), a biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical…